Search results :

Lubiprostone

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: A06AX03

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5
Nausea Nausea 8% - 29% 3% - 5% x x x x x
Diarrhoea Diarrhoea 7% - 12% 1% - 4% x x x x x
Loose stools 3% 0% x x x x x
Headache Headache 2% - 11% 1% - 5% x x x x x
Abdominal pain Abdominal pain 3% - 8% 1% - 5% x x x x x
Gastrointestinal pain Abdominal pain 3% - 8% 1% - 5% x x x x x
Flatulence Flatulence 3% - 6% 2% - 3% x x x x x
Abdominal distension Abdominal distension 3% - 6% 2% x x x x x
Dizziness Dizziness 3% 1% x x x x x
Syncope postmarketing x x x x x
Oedema Oedema 3% 1% x x x x x
Vomiting Vomiting 3% 0% - 2% x x x x x
Abdominal discomfort Abdominal discomfort 1% - 3% 1% x x x x x
Upset stomach 1% 1% x x x x
Gastrointestinal discomfort x x
Dyspepsia Dyspepsia 2% 1% x x x x x
Dyspnoea Dyspnoea 2% - 3% 0% x x x x x
Asthenia Fatigue 2% 1% x x x x x
Asthenia postmarketing x x x x x
Fatigue Fatigue 2% 1% x x x x x
Pain Pain 2% - 3% 0% x x x x x
Chest pain Chest discomfort 2% - 3% 0% x x x x x
Chest discomfort Chest discomfort 2% - 3% 0% x x x x x
Dry mouth Dry mouth 1% 1% x x x x x
Oedema peripheral Oedema peripheral 1% 1% x
Dermatitis Rash postmarketing x x x x x
Rash Rash postmarketing x x x x x
Hypersensitivity Hypersensitivity postmarketing x
Muscle spasms Cramp muscle postmarketing x x x x x
Muscle spasms postmarketing x x x x x
Swelling Swelling postmarketing x x x x
Shock Syncope postmarketing x x x x x
Syncope Syncope postmarketing x x x x x
Loss of consciousness Syncope postmarketing x x x x x
Tachycardia Tachycardia postmarketing x x x x x
Colitis ischaemic Colitis ischaemic postmarketing x
Malaise Malaise postmarketing x x x x x
Discomfort Malaise postmarketing x x x x x
Feeling abnormal Malaise postmarketing x x x x x
Ill-defined disorder Malaise postmarketing x x x x x
Throat tightness Throat tightness postmarketing x x x x
Constipation Chronic idiopathic constipation postmarketing x x x
Decreased appetite Anorexia x x x x
Decreased appetite x x x x x
Anxiety Anxiety x x x x x
Mental disorder Mental disorder x
Connective tissue disorder Connective tissue disorder x
Cough Cough x x x x x
Dysgeusia Dysgeusia x x x x x
Eructation Eructation x x x x x
Faecal incontinence Faecal incontinence x x x x x
Fibromyalgia Fibromyalgia x x x x
Functional gastrointestinal disorder Intestinal functional disorder x x x x x
Gastritis Gastritis x x x x
Gastrooesophageal reflux disease Gastrooesophageal reflux disease x x x x
Gastrointestinal disorder Gastrointestinal disorder x x x x x
Hyperhidrosis Hyperhidrosis x x x x x
Influenza Influenza x x x x x
Lethargy Lethargy x x x x
Mediastinal disorder Mediastinal disorder x x x x x
Nervous system disorder Nervous system disorder x x x x x
Palpitations Palpitations x x x x
Tremor Tremor x x x x x
Erythema Erythema x x x x
Pollakiuria Pollakiuria x x x x
Urinary tract infection Urinary tract infection x x x x
Weight increased Weight increased x x x x
Aspartate aminotransferase increased Aspartate aminotransferase increased x x x x
Alanine aminotransferase increased Alanine aminotransferase increased x x x x
Joint swelling Joint swelling x x x x x
Abdominal rigidity Abdominal rigidity x x
Malnutrition Malnutrition x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Myalgia Myalgia x x x x x
Musculoskeletal discomfort Myalgia x x x x x
Cold sweat Cold sweat x x x x x
Abdominal tenderness Abdominal tenderness x x
Frequent bowel movements Frequent bowel movements x x x x x
Rectal haemorrhage Rectal haemorrhage x x x x
Faeces hard Faeces hard x x x x
Electrolyte imbalance Electrolyte imbalance x x x x x
Defaecation urgency Defaecation urgency x x x x x
Blood potassium decreased Blood potassium decreased x
Laryngeal pain Pharyngolaryngeal pain x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

LUBIPROSTONE / AMITIZA

Side effects:52
Source:FDA

lubiprostone

Side effects:64
Source:FDA Structured Product Label

LUBIPROSTONE

Side effects:62
Source:FDA Structured Product Label

lubiprostone

Side effects:62
Source:FDA Structured Product Label

LUBIPROSTONE

Side effects:65
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label